These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32766674)

  • 1. Association Between Elevated suPAR, a New Biomarker of Inflammation, and Accelerated Aging.
    Rasmussen LJH; Caspi A; Ambler A; Danese A; Elliott M; Eugen-Olsen J; Hariri AR; Harrington H; Houts R; Poulton R; Ramrakha S; Sugden K; Williams B; Moffitt TE
    J Gerontol A Biol Sci Med Sci; 2021 Jan; 76(2):318-327. PubMed ID: 32766674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative childhood risk is associated with a new measure of chronic inflammation in adulthood.
    Rasmussen LJH; Moffitt TE; Eugen-Olsen J; Belsky DW; Danese A; Harrington H; Houts RM; Poulton R; Sugden K; Williams B; Caspi A
    J Child Psychol Psychiatry; 2019 Feb; 60(2):199-208. PubMed ID: 29741788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation.
    Rasmussen LJH; Petersen JEV; Eugen-Olsen J
    Front Immunol; 2021; 12():780641. PubMed ID: 34925360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.
    Persson M; Engström G; Björkbacka H; Hedblad B
    Atherosclerosis; 2012 Feb; 220(2):502-5. PubMed ID: 22119508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble urokinase plasminogen activator receptor is linearly associated with dietary quality and predicts mortality.
    Törnkvist PBS; Haupt TH; Rasmussen LJH; Ladelund S; Toft U; Pisinger C; Eugen-Olsen J
    Br J Nutr; 2019 Mar; 121(6):699-708. PubMed ID: 30626457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of GDF15 With Inflammation and Physical Function During Aging and Recovery After Acute Hospitalization: A Longitudinal Study of Older Patients and Age-Matched Controls.
    Tavenier J; Rasmussen LJH; Andersen AL; Houlind MB; Langkilde A; Andersen O; Petersen J; Nehlin JO
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):964-974. PubMed ID: 33428715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linking stressful life events and chronic inflammation using suPAR (soluble urokinase plasminogen activator receptor).
    Bourassa KJ; Rasmussen LJH; Danese A; Eugen-Olsen J; Harrington H; Houts R; Poulton R; Ramrakha S; Sugden K; Williams B; Moffitt TE; Caspi A
    Brain Behav Immun; 2021 Oct; 97():79-88. PubMed ID: 34224821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social isolation, loneliness, and inflammation: A multi-cohort investigation in early and mid-adulthood.
    Matthews T; Rasmussen LJH; Ambler A; Danese A; Eugen-Olsen J; Fancourt D; Fisher HL; Iversen KK; Schultz M; Sugden K; Williams B; Caspi A; Moffitt TE
    Brain Behav Immun; 2024 Jan; 115():727-736. PubMed ID: 37992788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between soluble urokinase plasminogen activator receptor (suPAR) concentration and psychiatric disorders - A systematic review and meta-analysis.
    Murphy J; Zierotin A; Mongan D; Healy C; Susai SR; O'Donoghue B; Clarke M; O'Connor K; Cannon M; Cotter DR
    Brain Behav Immun; 2024 Aug; 120():327-338. PubMed ID: 38857636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble urokinase plasminogen activator receptor (suPAR) levels in healthy pregnancy and preeclampsia.
    Toldi G; Bíró E; Szalay B; Stenczer B; Molvarec A; Rigó J; Vásárhelyi B; Bekõ G
    Clin Chem Lab Med; 2011 Nov; 49(11):1873-6. PubMed ID: 21722073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eleven genomic loci affect plasma levels of chronic inflammation marker soluble urokinase-type plasminogen activator receptor.
    Dowsett J; Ferkingstad E; Rasmussen LJH; Thørner LW; Magnússon MK; Sugden K; Thorleifsson G; Frigge M; Burgdorf KS; Ostrowski SR; Sørensen E; Erikstrup C; Pedersen OB; Hansen TF; Banasik K; Brunak S; ; Tragante V; Lund SH; Stefansdottir L; Gunnarson B; Poulton R; Arseneault L; Caspi A; Moffitt TE; Gudbjartsson D; Eugen-Olsen J; Stefánsson H; Stefánsson K; Ullum H
    Commun Biol; 2021 Jun; 4(1):655. PubMed ID: 34079037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in Behçet's disease and correlation with disease activity.
    Saylam Kurtipek G; Kesli R; Tuncez Akyurek F; Akyurek F; Ataseven A; Terzi Y
    Int J Rheum Dis; 2018 Apr; 21(4):866-870. PubMed ID: 27171829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
    Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events.
    Eapen DJ; Manocha P; Ghasemzadeh N; Patel RS; Al Kassem H; Hammadah M; Veledar E; Le NA; Pielak T; Thorball CW; Velegraki A; Kremastinos DT; Lerakis S; Sperling L; Quyyumi AA
    J Am Heart Assoc; 2014 Oct; 3(5):e001118. PubMed ID: 25341887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men.
    Haugaard SB; Andersen O; Hansen TW; Eugen-Olsen J; Linneberg A; Madsbad S; Olsen MH; Jørgensen T; Borch-Johnsen K; Jeppesen J
    Diabet Med; 2012 Apr; 29(4):479-87. PubMed ID: 22050462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis.
    Zimmermann HW; Koch A; Seidler S; Trautwein C; Tacke F
    Liver Int; 2012 Mar; 32(3):500-9. PubMed ID: 22098627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cadmium exposure is associated with soluble urokinase plasminogen activator receptor, a circulating marker of inflammation and future cardiovascular disease.
    Fagerberg B; Borné Y; Barregard L; Sallsten G; Forsgard N; Hedblad B; Persson M; Engström G
    Environ Res; 2017 Jan; 152():185-191. PubMed ID: 27792942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease.
    Mekonnen G; Corban MT; Hung OY; Eshtehardi P; Eapen DJ; Al-Kassem H; Rasoul-Arzrumly E; Gogas BD; McDaniel MC; Pielak T; Thorball CW; Sperling L; Quyyumi AA; Samady H
    Atherosclerosis; 2015 Mar; 239(1):55-60. PubMed ID: 25574858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in Plasma of Suicide Attempters.
    Ventorp F; Gustafsson A; Träskman-Bendz L; Westrin Å; Ljunggren L
    PLoS One; 2015; 10(10):e0140052. PubMed ID: 26451727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.